Loading...
Ambea AB (publ)
0RNX.L•LSE
HealthcareMedical - Care Facilities
£50.29
£0.00(0.00%)
Ambea AB (publ) (0RNX.L) Financial Performance & Statements
Review Ambea AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.63%
↑ 6.63%
Operating Income Growth
30.28%
↑ 30.28%
Net Income Growth
36.26%
↑ 36.26%
Operating Cash Flow Growth
20.54%
↑ 20.54%
Operating Margin
8.39%
↑ 8.39%
Gross Margin
57.85%
↑ 57.85%
Net Profit Margin
4.35%
↑ 4.35%
ROE
12.91%
↑ 12.91%
ROIC
8.56%
↑ 8.56%
Ambea AB (publ) (0RNX.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Ambea AB (publ) stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $3.64B | $3.56B | $3.52B | $3.48B |
Cost of Revenue | $130.00M | $2.82B | $2.98B | $117.00M |
Gross Profit | $3.51B | $736.00M | $539.00M | $3.37B |
Gross Profit Ratio | $0.96 | $0.21 | $0.15 | $0.97 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $318.00M | $334.00M | $347.00M |
Operating Expenses | $3.19B | $318.00M | $334.00M | $3.11B |
Total Costs & Expenses | $3.32B | $3.14B | $3.31B | $3.23B |
Interest Income | $0.00 | $0.00 | $0.00 | $116.00M |
Interest Expense | $115.00M | $118.00M | $119.00M | $116.00M |
Depreciation & Amortization | $345.00M | $343.00M | $342.00M | $337.00M |
EBITDA | $664.00M | $798.00M | $547.00M | $593.00M |
EBITDA Ratio | $0.18 | $0.22 | $0.16 | $0.17 |
Operating Income | $318.00M | $418.00M | $205.00M | $256.00M |
Operating Income Ratio | $0.09 | $0.12 | $0.06 | $0.07 |
Other Income/Expenses (Net) | -$114.00M | -$81.00M | -$75.00M | -$116.00M |
Income Before Tax | $204.00M | $337.00M | $130.00M | $140.00M |
Income Before Tax Ratio | $0.06 | $0.09 | $0.04 | $0.04 |
Income Tax Expense | $57.00M | $71.00M | $35.00M | $29.00M |
Net Income | $147.00M | $266.00M | $95.00M | $111.00M |
Net Income Ratio | $0.04 | $0.07 | $0.03 | $0.03 |
EPS | $1.76 | $3.14 | $1.10 | $1.25 |
Diluted EPS | $1.75 | $3.13 | $1.09 | $1.25 |
Weighted Avg Shares Outstanding | $83.72M | $84.61M | $86.62M | $88.86M |
Weighted Avg Shares Outstanding (Diluted) | $84.003M | $84.87M | $86.79M | $88.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan